Samuel Backenroth, CFO, Treasurer & Secretary at NeuBase Therapeutics, holds 11.63K shares in NeuBase Therapeutics (Ticker: NBSE). Most recently, Samuel Backenroth Bought $1,000 shares of NeuBase Therapeutics on May 04, 2020 for an estimated value of 6.00K.
What is the percentage of profitable transactions made by Samuel Backenroth?
The percentage of profitable transactions made by Samuel Backenroth is 0%.
What is the average return per transaction made by Samuel Backenroth?
The average return per transaction made by Samuel Backenroth is -58.90%.
What stocks does Samuel Backenroth hold?
Samuel Backenroth holds: NBSE stocks.
What was Samuel Backenroth’s latest transaction?
Samuel Backenroth latest transaction was an Informative Buy of $6.00K.
What was Samuel Backenroth's most profitable transaction?
Samuel Backenroth’s most profitable transaction was an Informative Buy of NBSE stock on May 4, 2020. The return on the trade was -4.70%.
What is Samuel Backenroth's role in NeuBase Therapeutics?
Samuel Backenroth's role in NeuBase Therapeutics is CFO, Treasurer & Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.